AVEANNA HEALTHCARE ($AVAH) posted quarterly earnings results for Q4 2025 on Thursday, March 19th. The company reported earnings of $0.17 per share, beating estimates of $0.14 by $0.03. The company also reported revenue of $662,480,000, beating estimates of $658,374,300 by $4,105,700.
You can see Quiver Quantitative's $AVAH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AVEANNA HEALTHCARE Insider Trading Activity
AVEANNA HEALTHCARE insiders have traded $AVAH stock on the open market 44 times in the past 6 months. Of those trades, 0 have been purchases and 44 have been sales.
Here’s a breakdown of recent trading of $AVAH stock by insiders over the last 6 months:
- PAUL R VIGANO has made 0 purchases and 6 sales selling 11,500,000 shares for an estimated $103,500,000.
- ROBERT M JR WILLIAMS has made 0 purchases and 6 sales selling 11,500,000 shares for an estimated $103,500,000.
- WHITNEY EQUITY PARTNERS VII, LLC J.H. has made 0 purchases and 2 sales selling 9,597,968 shares for an estimated $86,381,712.
- JEFF SHANER (Chief Executive Officer) has made 0 purchases and 6 sales selling 546,869 shares for an estimated $4,101,383.
- EDWIN C. REISZ (Chief Administrative Officer) has made 0 purchases and 6 sales selling 213,013 shares for an estimated $1,610,700.
- MATTHEW BUCKHALTER (Chief Financial Officer) has made 0 purchases and 6 sales selling 89,107 shares for an estimated $697,150.
- PATRICK A. CUNNINGHAM (Chief Compliance Officer) has made 0 purchases and 6 sales selling 85,175 shares for an estimated $655,556.
- DEBORAH STEWART (SVP, Chief Accounting Officer) has made 0 purchases and 6 sales selling 64,431 shares for an estimated $501,322.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AVEANNA HEALTHCARE Hedge Fund Activity
We have seen 129 institutional investors add shares of AVEANNA HEALTHCARE stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J.H. WHITNEY EQUITY PARTNERS VII, LLC removed 9,597,968 shares (-20.9%) from their portfolio in Q4 2025, for an estimated $78,415,398
- LITTLEJOHN & CO LLC removed 3,140,105 shares (-52.9%) from their portfolio in Q4 2025, for an estimated $25,654,657
- SUMMIT PARTNERS L P removed 2,100,000 shares (-21.8%) from their portfolio in Q4 2025, for an estimated $17,157,000
- AUSTRALIANSUPER PTY LTD removed 1,774,837 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,500,418
- EMERALD ADVISERS, LLC added 1,748,725 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,287,083
- VANGUARD GROUP INC added 1,535,351 shares (+38.0%) to their portfolio in Q4 2025, for an estimated $12,543,817
- CITADEL ADVISORS LLC added 1,511,417 shares (+3938.3%) to their portfolio in Q4 2025, for an estimated $12,348,276
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AVEANNA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $AVAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 12/08/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for AVEANNA HEALTHCARE, check out Quiver Quantitative's $AVAH forecast page.
AVEANNA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $AVAH recently. We have seen 6 analysts offer price targets for $AVAH in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $11.0 on 01/16/2026
- A.J. Rice from UBS set a target price of $10.0 on 01/15/2026
- Ben Hendrix from RBC Capital set a target price of $11.0 on 01/15/2026
- Sean Dodge from BMO Capital set a target price of $11.0 on 11/13/2025
- David Macdonald from Truist Securities set a target price of $10.0 on 11/07/2025
- Brian Tanquilut from Jefferies set a target price of $12.5 on 10/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
